Semaglutide Salt Form vs Base Form: Why It Matters for Dosing

If you use compounded semaglutide, you may have noticed labels referencing "semaglutide" or "semaglutide sodium." This is not just a labeling technicality -- it directly impacts the dose of active medication you receive and can be the difference between an effective and a subtherapeutic dose.

The Basics: What Are Salt and Base Forms?

In pharmaceutical chemistry, many drugs exist in different chemical forms. The two relevant forms for semaglutide are:

Think of it this way: semaglutide base is like measuring pure sugar, while semaglutide sodium is like measuring sugar with its packaging still on. The active part (sugar) is the same, but the total weight includes the packaging (sodium ion).

Why This Matters for Your Dose

Dose Conversion Table

Practical Impact on Patients

Here is where this gets important in real-world use:

Scenario 1: Pharmacy labels correctly

A pharmacy using semaglutide sodium labels the vial as "Semaglutide Sodium 5.75 mg/mL" to deliver the equivalent of 5 mg/mL base. The patient receives the correct therapeutic dose. This is proper practice.

Scenario 2: Pharmacy does not adjust

A pharmacy using semaglutide sodium labels the vial as "Semaglutide 5 mg/mL" without adjusting for the salt form. The patient actually receives approximately 4.35 mg/mL of active semaglutide -- about 13% less than intended. Over time, this could lead to slower weight loss results or the perception that the medication is not working.

How to Check Your Medication

Here are steps you can take to ensure proper dosing:

1. Ask your pharmacy directly: "Do you use semaglutide base or semaglutide sodium salt?"
2. Check the Certificate of Analysis: The COA from the API supplier will specify which form was purchased
3. Read the vial label carefully: Look for "semaglutide" vs. "semaglutide sodium"
4. Confirm with your prescriber: Ensure your provider and pharmacy are aligned on dosing conventions
5. Request potency test results: Third-party testing should confirm the actual concentration in the finished product

The Regulatory Perspective

The FDA has specifically addressed this issue, noting that compounding pharmacies must account for the salt form when calculating doses. The agency has stated that failing to properly convert between salt and base forms can lead to dosing errors that put patients at risk.

Brand-name Wegovy and Ozempic doses are always expressed as semaglutide base. Any compounded medication aiming to replicate these doses should either use semaglutide base directly or mathematically adjust upward if using the sodium salt form.

Does This Apply to Tirzepatide?

The salt vs. base distinction exists for tirzepatide as well, though it is less commonly discussed because most compounding pharmacy API suppliers provide tirzepatide in its base form. However, the same principle applies: always confirm which form your pharmacy uses and whether dosing has been adjusted accordingly.

Key Takeaways

• Semaglutide exists in base and sodium salt forms with different molecular weights
• The salt form requires approximately 15% more material to deliver the same active dose
• Reputable pharmacies clearly label which form they use and adjust dosing
• Always ask your compounding pharmacy which form they use
• If you are not seeing expected results, the salt/base distinction could be a factor